Freudenberg Medical Executive and Leadership Team

Kurt Ziminski, the Chief Financial Officer at Freudenberg Medical, directs all fiscal planning and capital allocation strategies. Overseeing global financial reporting, the Chief Financial Officer ensures alignment with long-term growth objectives for medical device manufacturing. This leadership role involves managing complex budgetary frameworks across international production sites to maintain profitability. By optimizing cost structures and investment portfolios, Kurt Ziminski directly impacts the financial health of the organization. Ziminski secures the necessary resources for research and development, enabling the company to advance thermoplastic injection and catheter system technologies. Through rigorous oversight of fiscal compliance and risk management, the Chief Financial Officer supports the expansion of market share within the competitive medical device landscape. Ultimately, Ziminski drives sustainable economic performance while upholding the high standards of excellence expected within the broader Freudenberg corporate structure.

David Balcom, the Chief Operating Officer & Board Member at Freudenberg Medical, directs all manufacturing operations and supply chain logistics. Overseeing the production of balloon tubing and insert molding, the Chief Operating Officer & Board Member ensures seamless integration between engineering and assembly lines. This leadership role involves scaling production capacity to meet the rising demand for complex catheter systems across North American and European markets. By implementing lean manufacturing principles, David Balcom improves operational efficiency and reduces lead times for critical medical components. Balcom collaborates with the Board to define strategic priorities regarding facility expansion and technological upgrades. Through constant monitoring of quality control metrics, the Chief Operating Officer & Board Member maintains the rigorous safety standards required for medical device manufacturing. Ultimately, Balcom optimizes the entire production lifecycle to ensure consistent delivery of high-performance products to global healthcare partners.

Roberto Grateron, the President Specialty Components SBU at Freudenberg Medical, directs the development and commercialization of specialized medical components. Overseeing the design of tapes, cords, and needles, the President Specialty Components SBU ensures that product offerings meet the evolving needs of the medical device industry. This leadership role involves managing cross-functional teams to accelerate the transition from prototype to mass production. By fostering innovation in material science, Roberto Grateron expands the portfolio of high-precision components available to global clients. Grateron coordinates with internal engineering departments to refine manufacturing processes for complex insert molding applications. Through strategic market analysis, the President Specialty Components SBU identifies emerging opportunities for growth in the specialty components sector. Ultimately, Grateron drives the technical advancement of the business unit, ensuring that every component manufactured adheres to the highest quality benchmarks for patient safety and clinical efficacy.

Oliver Krause-Huckleberry, the President at Freudenberg Medical, directs the overarching corporate strategy and global business vision. Overseeing the integration of diverse manufacturing units, the President ensures that the company maintains a unified approach to medical device innovation. This leadership role involves guiding the executive team toward achieving long-term objectives in thermoplastic injection and advanced catheter systems. By cultivating partnerships with healthcare providers and medical technology firms, Oliver Krause-Huckleberry expands the reach of the organization across international markets. Krause-Huckleberry monitors industry trends to anticipate shifts in regulatory requirements and technological advancements. Through consistent communication with stakeholders, the President aligns internal capabilities with the mission of improving patient outcomes through superior engineering. Ultimately, Krause-Huckleberry drives the strategic direction of the company, ensuring that all operational activities support the core commitment to quality and excellence in the medical device manufacturing sector.